Corazzelli, G., Frigeri, F., Arcamone, M., Lucania, A., RosariaVilla, M., Morelli, E., . . . Pinto, A. (2011). Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high ‘life threat’ impact cardiopathy. Blackwell Publishing Ltd.
Citação norma ChicagoCorazzelli, Gaetano, et al. Biweekly Rituximab, Cyclophosphamide, Vincristine, Non-pegylated Liposome-encapsulated Doxorubicin and Prednisone (R-COMP-14) in Elderly Patients With Poor-risk Diffuse Large B-cell Lymphoma and Moderate to High ‘life Threat’ Impact Cardiopathy. Blackwell Publishing Ltd, 2011.
MLA CitationCorazzelli, Gaetano, et al. Biweekly Rituximab, Cyclophosphamide, Vincristine, Non-pegylated Liposome-encapsulated Doxorubicin and Prednisone (R-COMP-14) in Elderly Patients With Poor-risk Diffuse Large B-cell Lymphoma and Moderate to High ‘life Threat’ Impact Cardiopathy. Blackwell Publishing Ltd, 2011.